Bisphosphonate Treatment of Osteogenesis Imperfecta

PHASE2CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Osteogenesis Imperfecta
Interventions
DRUG

Zoledronic Acid

Trial Locations (10)

19899

Alfred I. DuPont Hospital for Children, Wilmington

37232

Vanderbilt University Medical Center, Nashville

43205

Children's Hospital, Columbus

45229

Children's Hospital Medical Center, Cincinnati

61637

St. Jude Children's Research Hospital, Peoria

68198

Children's Hospital, Omaha

77030

Texas Children's Hosptial, Houston

83702

Intermountain Orthopedics, Boise

90024

UCLA - Division of Pediatric Nephrology, Los Angeles

97201

Oregon Health Sciences University, Portland

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY